Boston Scientific buys Harker School grad's med-tech business for $275M
Boston Scientific Corp. said Monday that it has bought nVision Medical Corp., a med-tech firm founded by a Harker School graduate that's developing a device to screen women for ovarian cancer.
The Star Tribune of Minneapolis reported that Massachusetts-based Boston Scientific (NYSE: BSX) will pay $150 million upfront and another $125 million in later payments to acquire San Bruno-based nVision.
RELATED: Read Boston Scientific's full announcement
NVision had raised only about $17 mill ion in funding…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Mark Reilly Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Graduation | Health Management | Ovarian Cancer | Ovaries | Women